July 25, 2007 -- WuXi PharmaTech of Shanghai filed for an IPO on the NYSE. This gives the world a look at just how successful the biggest contract research organization (CRO) in China has been in its first six years of life. WuXi is offering 13,188,979 ADSs in the IPO in a price range of $11 to $13, representing 22% of all shares outstanding. If the offering can maintain the midpoint figure of $12, WuXi would have a market capitalization of $714.6 million. More details...
